Management of carotid artery stenosis: comparing endarterectomy and stenting

Ricardo A Hanel1, Andrew R Xavier, Jawad F Kirmani

  • 1Department of Neurosurgery, Millard Fillmore Hospital, 3 Gates Circle, Buffalo, NY 14209-1194, USA.

Current Cardiology Reports
|February 14, 2003
PubMed

Insights

Stroke, a leading cause of death and disability, affects 750,000 annually. Carotid artery stenosis is a major risk factor, but treatments like carotid endarterectomy (CEA) and angioplasty with stenting (CAS) can reduce stroke risk.

Area of Science:

  • Vascular Neurology
  • Interventional Cardiology

Background:

  • Stroke is a leading cause of death and disability, with significant economic impact.
  • Cervical internal carotid artery occlusive disease accounts for approximately 25% of ischemic strokes.
  • Carotid stenosis increases stroke risk through embolism and hypoperfusion.

Purpose of the Study:

  • To review the established role of carotid endarterectomy (CEA) in stroke risk reduction.
  • To introduce carotid angioplasty and stenting (CAS) as a contemporary alternative to CEA.
  • To highlight patient populations where CAS may be preferred over CEA.

Main Methods:

  • Review of landmark clinical trials including NASCET, ECST, and ACAS.
  • Discussion of the evolution and application of carotid angioplasty and stenting (CAS).
  • Comparative analysis of CEA and CAS in managing carotid stenosis.

Main Results:

  • CEA has demonstrated substantial stroke risk reduction in specific grades of carotid stenosis.
  • CAS has emerged as a viable alternative to CEA.
  • CAS may be particularly beneficial for patients with increased CEA complication risks.

Conclusions:

  • Carotid endarterectomy remains a proven intervention for select patients with symptomatic carotid stenosis.
  • Carotid angioplasty and stenting offers a valuable alternative, especially in high-risk surgical candidates.
  • Both CEA and CAS play crucial roles in managing carotid atherovascular disease to prevent ischemic stroke.

Related Concept Videos

Aneurysm III: Interprofessional Care01:26

Aneurysm III: Interprofessional Care

Aneurysm management involves either conservative medical therapy or surgical intervention, depending on the size and symptoms of the aneurysm. Conservative management is generally reserved for smaller, asymptomatic aneurysms, while larger or symptomatic aneurysms often necessitate surgical repair.Conservative Medical TherapyFor small, asymptomatic aneurysms, particularly abdominal aortic aneurysms (AAA) less than 5.5 centimeters in diameter, conservative medical therapy is recommended. This...
Atherosclerosis III: Management01:26

Atherosclerosis III: Management

Management of atherosclerosis involves an integrated strategy encompassing pharmacological treatment, surgical interventions, lifestyle changes, and nutrition therapy to address the multifactorial nature of the disease.Pharmacological TherapyA cornerstone of atherosclerosis management is the use of pharmacological agents. Statins, such as atorvastatin, are pivotal in inhibiting HMG-CoA reductase, an enzyme that catalyzes an initial step in cholesterol synthesis in the liver. This reduction in...
Peripheral Artery Disease III: Interprofessional Care01:27

Peripheral Artery Disease III: Interprofessional Care

Peripheral Artery Disease (PAD) is characterized by narrowed arteries that diminish blood flow to the extremities. Effective management of PAD requires an interprofessional approach involving various healthcare professionals. The critical aspects of interprofessional care for PAD patients focus on risk factor modification, drug therapy, exercise therapy, nutrition therapy, critical limb ischemia care, and interventional radiology and surgical procedures.The primary treatment goal for PAD...
Coronary Artery Disease V: Interprofessional Care01:27

Coronary Artery Disease V: Interprofessional Care

Interprofessional care for coronary artery disease includes pharmacological therapy and revascularization procedures.Pharmacological therapy for Coronary Artery Disease (CAD) aims to manage symptoms, prevent complications, and improve patient outcomes through various classes of medications:Antiplatelet Agents:Aspirin and Clopidogrel: These medications inhibit platelet aggregation, preventing blood clots, which is crucial for avoiding heart attacks and strokes. Doctors often prescribe these...
Angina IV: Management01:26

Angina IV: Management

IntroductionThe management of angina requires a comprehensive approach that includes pharmacological therapies, medical procedures, and lifestyle modifications.Pharmacological TherapiesAntiplatelet agents, such as aspirin, clopidogrel, prasugrel, and ticagrelor, play a pivotal role in preventing thrombus formation in patients with angina. These medications inhibit platelet aggregation and reduce the likelihood of myocardial infarction and other cardiovascular events.Anticoagulants, including...
Mitral Stenosis III: Medical Management01:26

Mitral Stenosis III: Medical Management

Mitral stenosis, a condition marked by the narrowing of the mitral valve, necessitates an integrated approach for effective management. This approach includes preventative measures, medical therapy, and surgical interventions to reduce symptoms and prevent complications.PreventionPrevention of mitral stenosis primarily focuses on reducing the incidence of bacterial infections, particularly streptococcal infections, which can lead to rheumatic fever and subsequent valvular damage. Timely...